Last edition
News about " AI-driven drug discovery"
Evotec SE and Almirall S.A. Advance Dermatology Drug Candidate to Preclinical Stage
The Evotec–Almirall collaboration showcases the power of AI-driven drug discovery, rapidly advancing a promising dermatology candidate toward clinical development for unmet medical needs.
AI-driven Drug Discovery | 05/05/2026 | By News Bureau
TaiGen Biotechnology doses first participant in Phase I trial of ISM4808, an AI-designed oral therapy from Insilico Medicine for chronic kidney disease-related anemia.
AI Driven Drug Discovery | 09/03/2026 | By News Bureau | 189
Illumina Launches Billion Cell Atlas to Power AI-Driven Drug Discovery
Illumina, Inc. has launched the Illumina Billion Cell Atlas, the world’s largest genome-wide genetic perturbation dataset, designed to accelerate AI-enabled drug discovery across the pharmaceutical industry.
AI-Driven Drug Discovery | 15/01/2026 | By Darshana | 257
Pierre Fabre, Iktos Partner on AI-Driven Oncology Drug Discovery Collaboration
The partnership between Pierre Fabre and Iktos integrates generative AI and automated chemistry to accelerate small-molecule cancer drug development.
AI-driven Drug Discovery | 09/01/2026 | By News Bureau | 225
Insilico Medicine and Servier Forge AI-Driven Oncology Drug Discovery Alliance
Insilico Medicine, a global leader in artificial intelligence–driven drug discovery, has entered into a multi-year research and development collaboration with Servier, an independent international pharmaceutical company governed by a foundation.
AI-Driven Drug Discovery | 06/01/2026 | By Darshana | 106
Merck KGaA Inks Up to USD 3 Billion AI-Driven Drug Discovery Deal with Valo Health
Merck KGaA has entered into a major strategic collaboration with Valo Health to use Valo’s AI-powered human causal biology platform for discovering and developing new treatments for Parkinson’s disease and related disorders.
AI-Driven Drug Discovery | 21/11/2025 | By Darshana | 472
Bahrain's sovereign fund partners with SandboxAQ to accelerate AI-driven drug discovery
Bahrain’s sovereign wealth fund, Mumtalakat, has entered into a strategic partnership with SandboxAQ, a USA-based company specialising in artificial intelligence and quantum technologies, to fast-track drug discovery and build biotech assets valued at up to USD 1 billion.
AI-driven Drug Discovery | 28/10/2025 | By Darshana | 312
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy